Abstract
Material used comprises primarily information provided by manufacturers in packaging labels and by the FDA in various publications.
Highlights
Women do not receive information necessary for the safe use of contraceptive pills and devices -- neither from all pharmaceutical companies nor from healthcare providers
The method consists in an analysis of information provided by various sources, such as manufacturers, FDA, scholarly articles, and popularizing publications emanating from academic institutions and clinics
Thousands of women experienced severe medical problems and filed lawsuits against the company in the US and in other countries: “The implant has had a troubled history. It has been the subject of an estimated 16,000 lawsuits or claims filed by women who reported severe injuries, including perforation of the uterus and the fallopian tubes
Summary
Comprehensive, complete, and reliable information on all available methods of contraception is difficult to obtain. Pharmaceutical companies should be obliged by law to inform the users of their products in a comprehensible manner about all risks and potential complications without using a confusing, deceptive, or misleading vocabulary. Material used comprises primarily information provided by manufacturers in packaging labels and by the FDA in various publications. In instances where it seems appropriate, pertinent scholarly articles published in the most prestigious professional journals are critically analysed
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call